Thus, CWs could reverse an immunosuppressive tumor microenvironment by increasing IFNγ production and inhibiting PD-L1 expression, which then probably activated autologous CIK that synergized (Z)-BP and acted on the GBM. The gene discussed is CD274; the disease is glioblastoma.